- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02452203
Examining the Effects of Reduced Environmental Stimulation on the Brain
18. September 2020 aktualisiert von: Justin Feinstein, Laureate Institute for Brain Research, Inc.
The studies proposed in this protocol aim to explore the anxiolytic properties of floating as it relates to the central and autonomic nervous system.
Studienübersicht
Detaillierte Beschreibung
The human brain is constantly bombarded with sensory information from the external world.
This series of studies aim to explore the effects of reducing environmental stimulation using specially designed floatation pools that minimize visual, auditory, tactile, proprioceptive, and thermal input to the brain.
Previous research has shown that "floating" in this unique setting can significantly reduce levels of anxiety, stress, blood pressure, and cortisol, while significantly increasing levels of both subjective and physiological forms of relaxation.
Much of this past research contained various methodological weaknesses, including small sample sizes, lack of a control group, and no longitudinal follow-up.
Moreover, very little is known about the potential benefits of floating in clinical populations, and essentially nothing is known about the effects of floating on the brain.
The studies proposed in this protocol aim to further explore floating's potentially salubrious effect on the autonomic nervous system, while beginning to investigate its largely unknown effect on the central nervous system.
The researchers have attempted to improve upon the weaknesses of past research by using larger sample sizes, a control group, and a longitudinal design.
The current project is focused on documenting the subjective, behavioral, physiological and neural effects of floating in healthy and anxious populations.
The subjective effects of floating will be examined using self-report measures and the experience sampling method.
The behavioral effects of floating will be examined using measures of interoceptive awareness and distress tolerance.
The physiological effects of floating will be examined using waterproof and wireless tracking of blood pressure, heart rate, respiration, and movement, in addition to collecting measures of cortisol and magnesium.
A portable electroencephalography (EEG) system will be used to measure sleep during the nights before and after a float experience.
The neural effects of floating will be examined using waterproof and wireless EEG collected during the float experience, as well as using functional magnetic resonance imaging (fMRI) collected before and immediately after floating.
Using a longitudinal within-subject design, the researchers have a unique opportunity to assess not only functional brain changes, but also structural brain changes induced by repeated exposures to floating.
An active control condition aims to control for the effects of simple relaxation by collecting all of the same measures while participants lay supine in a zero-gravity chair situated in a quiet, dimly lit room.
This program of research constitutes the first systematic investigation of floating on the body and the brain, and the findings have the potential to illuminate the physiological and neural correlates of the deep relaxation induced by the floating experience.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
56
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Oklahoma
-
Tulsa, Oklahoma, Vereinigte Staaten, 74136
- Laureate Institute for Brain Research
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
18 Jahre bis 55 Jahre (Erwachsene)
Akzeptiert gesunde Freiwillige
Ja
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- Participants must be between 18-55 years of age, free of any current or past neurological or psychiatric illness, and capable of performing all tasks during each session of the experiment.
- They must be able to provide written informed consent and must have sufficient proficiency in the English language to understand and complete interviews, questionnaires, and all other study procedures.
Exclusion Criteria:
- Participant meets criteria for a DSM5 Axis-1 disorder.
- Participant endorses current suicidal ideation with intent or plan.
- Participant fails to adhere to our "Pre-float checklist".
- Participant is morbidly obese (BMI > 40).
- Certain drugs or medications consumed within the past week including any psychoactive drugs (e.g., benzodiazepines, opiates, selective serotonin reuptake inhibitors, dopamine agonists, barbiturates, MDMA, LSD, psilocybin, peyote, phencyclidine, ketamine). For all other medications, we require the participant to be stably medicated prior to participation (defined as having taken the medication for 6 weeks or longer).
- Participant has a history of unstable liver or renal insufficiency; glaucoma; diabetes; significant and unstable cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, or metabolic disturbance; or any other condition that, in the opinion of the investigator, would make participation not be in the best interest (e.g., compromise the well-being) of the subject or that could prevent, limit, or confound the protocol-specified assessments.
- Pregnancy as detected by a urine test.
- Non-correctable vision or hearing problems.
- MRI contraindications including: cardiac pacemaker, metal fragments in eyes/skin/body (shrapnel), aortic/aneurysm clips, prosthesis, by-pass surgery/coronary artery clips, hearing aid, heart valve replacement, shunt (ventricular or spinal), electrodes, metal plates/pins/screws/ wires, or neuro/bio-stimulators (TENS unit), persons who have ever been a professional metal worker/welder, history of eye surgery/eyes washed out because of metal, vision problems uncorrectable with lenses, inability to lie still on one's back for 60-120 minutes; prior neurosurgery; tattoos or cosmetic makeup with metal dyes, unwillingness to remove body piercings, and pregnancy.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Floating
The participant will float supine in water with a high concentration of Epsom salt for 90 minutes.
|
Floating in either a pool saturated with Epsom salt or in a zero-gravity chair
|
|
Placebo-Komparator: Chair
The participant will lay in the supine position while reclined in a zero-gravity chair for 90 minutes.
|
Floating in either a pool saturated with Epsom salt or in a zero-gravity chair
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Brain activation changes in limbic and paralimbic neural circuitry from pre- to post-float as measured with functional magnetic resonance imaging (fMRI)
Zeitfenster: fMRI will be undertaken before floating and then immediately following the 3rd float session, an average time frame of 3 weeks
|
MRI scan to measure the blood flow changes in the brain
|
fMRI will be undertaken before floating and then immediately following the 3rd float session, an average time frame of 3 weeks
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Ermittler
- Hauptermittler: Justin Feinstein, PhD, Laureate Institute for Brain Research
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
1. Mai 2015
Primärer Abschluss (Tatsächlich)
1. Dezember 2019
Studienabschluss (Tatsächlich)
31. Dezember 2019
Studienanmeldedaten
Zuerst eingereicht
18. Mai 2015
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
21. Mai 2015
Zuerst gepostet (Schätzen)
22. Mai 2015
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
22. September 2020
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
18. September 2020
Zuletzt verifiziert
1. September 2020
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- float-fMRI-1
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Floating
-
Jiang XumeiGuangdong Provincial Hospital of Traditional Chinese MedicineUnbekannt
-
Medical University of South CarolinaThe Skin Center Dermatology GroupBeendetVerruca vulgaris | Molluscum contagiosumVereinigte Staaten
-
Laureate Institute for Brain Research, Inc.Aktiv, nicht rekrutierend
-
Medical University of South CarolinaThe Skin Center Dermatology GroupAbgeschlossenVerruca vulgaris | Molluscum contagiosum HautinfektionVereinigte Staaten